METABOLIC SYNDROME VS INSULIN RESISTANCE SYNDROME (A CLUSTER OF COMPONENTS AND STRATEGIES FOR TREATMENT)
ABSTRACT: Metabolic Syndrome =
MS (in which abdominal Obesity is the culprit of the MS) is defined by NCEP-ATP
III in 2001, whereas Dysmetabolic Syndrome = DMS and Insulin Resistance
Syndrome = IRS are recommended terms by AACE (in 2002) and ACE (in 2002),
respectively. Both AACE and ACE stated that insulin resistance plays central
role in the syndrome. All these terms of the syndrome are originally and
firstly coined by Reaven as Syndrome-X in 1988, and then Metabolic Syndrome-X in
1999. Either MS or DMS or IRS has become major issues because of its impact on
the risks of Type 2 DM (T2DM) development and cardiovascular diseases. The
criteria of MS, IRS (including its risk factors), and the clusters of
components belong to MS and IRS, are listed in this paper. Rational strategies
for the treatment of MS and IRS are focused on obesity and insulin resistance,
respectively, and can be summarized as follows: A. Improving insulin
sensitivity and lifestyle (weight loss 5-10%, aerobic exercise ± 30-40 min, 4
times/week). B. Pharmacological Interventions directed to the targets for
(mmHg, ml/dl): Blood Pressure < 130/85, and 130/80 in diabetic patients, Fasting
Plasma Glucose (FPG) < 110 or 2 Hour Post-75
Glucose Challenge < 140, Triglyceride (TG) < 150, and HDL-Cholesterol
> 40 for men, and > 50 for women. Clinical evidence-based data supported,
that Metformin (UKPDS Outcomes), Sibutramine (STORM Landmark Trial), and
Orlistat (XENDOS Study), to date, are the promising drugs for the treatment of
MS/IRS. However, the drugs specifically
to improve the insulin sensitivity are hoped to treat this Syndrome.
Conclusions: Syndrome-X, Metabolic Syndrome-X, MS, DMS, or IRS, all have become
major issues because of their roles in the development of either T2DM or
Cardiovascular Diseases. The cluster of components of this Syndrome and its
risk factors should be well recognized. Improving insulin sensitivity, losing
body weight, aerobic exercise, and pharmacologic interventions (Metformin, Sibutramin,
Orlistat) are rational strategies for the treatment of MS/IRS.
Keywords: metabolic syndrome,
dysmetabolic syndrome, insulin resistance syndrome, type 2 diabetes mellitus, cardiovascular
diseases
Author: Askandar Tjokroprawiro
Journal Code: jpkedokterangg050020

Artikel Terkait :
Jp Kedokteran gg 2005
- Treatment of taeniasis and cysticercosis with praziquantel and albendazole
- The benefits of progesterone therapy in imminent abortion
- PM10 as Predictor of Ventilation Efficiency of Houses in Relation to Health Effect
- Fatty acids intake among diverse ethnic groups in Indonesia
- The effects of balanced low calorie diet on body composition and serum leptin of obese women
- QT dispersion, a simple tool to predict ventricular tachyarrhythmias and/or sudden cardiac death after myocardial infarction
- Endoscopical appearances of nonsteroidal anti inflammatory drug (NSAID)- enteropathy
- Role of general practitioner in the management of acute myocardial infarction
- Genotyping of hepatitis B virus from dried and stored serum on filter paper
- Development of bioassay for pathogenecity testing of Ureaplasma urealyticum as part of host-pathogen communication
- Detection of GAD65 autoantibodies of type-1 diabetes using anti-GAD65-abs reagent produced from bovine brain tissue
- The use of ceftriaxone impregnated beads in the management of chronic osteomyelitis
- The correlation between total lymphocyte count and the number of candida colony from the oral cavity in HIV/AIDS patients
- Survival rate and prognostic factors in advanced cervical cancer patients accompanied by renal impairment
- Left ventricular diastolic dysfunction in type 2 diabetes mellitus patient without cardiovascular disease: the association with microalbuminuria
- Hormonal contraception as a risk factor for obesity
- Effect of irrigating fluid temperature on core body temperature during transurethral resection of the prostate
- T-lineage blast crisis of chronic myelogenous leukemia: simple record of 4 cases
- Intracranial germ cell tumour with extra cranial extension in a four month old infant – a case report
- Drospirinone: new generation of progestogen
- Implementation of 25-well culture plates for M. tuberculosis drug susceptibility testing in Indonesia
- Cytosolic estrogen and progesterone receptor content in the endometriotic tissues and endometrium in women with and without endometriosis
- Nutritional status of hyperlipidemics elderly in Indonesia according to body mass lndex (study in four Indonesian big cities)
- Age, duration of work, noise and vibration in inducing hearing and balance impairments
- Presurgical cytologic diagnostic test of uterine cavity in ovarian malignant tumor